Lorillard Inc. (LO) Financials Nov 17, 2014, 4:26

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Lorillard Inc. (LO) Financials Nov 17, 2014, 4:26 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Lorillard Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.69B 4.05B 4.45B 4.64B 4.97B
Cost of Goods Sold (COGS) incl. D&A 633M 699M 780M 855M 991M
COGS excluding D&A 601M 664M 743M 816M 941M
Depreciation & Amortization Expense 32M 35M 37M 39M 50M
Depreciation 32M 35M 37M 39M 44M
Amortization of Intangibles 0 0 0 0 6M
Gross Income 3.05B 3.35B 3.67B 3.78B 3.98B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 286M 301M 333M 358M 685M
Research & Development 19M 19M 22M 20M 21M
Other SG&A 267M 282M 311M 338M 664M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.22B 1.3B 1.42B 1.52B 1.22B
EBIT after Unusual Expense (1.22B) (1.3B) (1.42B) (1.52B) (1.22B)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 5M 4M 3M 4M 2M
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 33M 118M 149M 178M 196M
Gross Interest Expense 33M 118M 149M 178M 196M
Interest Capitalized 0 0 0 0 0
Pretax Income 1.52B 1.64B 1.77B 1.73B 1.88B
Income Tax 571M 606M 654M 629M 704M
Income Tax - Current Domestic 580M 601M 668M 641M 746M
Income Tax - Current Foreign - - - - 0
Income Tax - Deferred Domestic (9M) 5M (14M) (12M) (41M)
Income Tax - Deferred Foreign - - - - (1M)
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 (3M) (3M) (3M)
Consolidated Net Income 948M 1.03B 1.11B 1.1B 1.18B
Minority Interest Expense 0 0 0 0 0
Net Income 948M 1.03B 1.11B 1.1B 1.18B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 948M 1.03B 1.11B 1.1B 1.18B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 948M 1.03B 1.11B 1.1B 1.18B
EPS (Basic) 1.92 2.26 2.67 2.82 3.15
Basic Shares Outstanding 493.44M 454.77M 417.33M 389.27M 372.96M
EPS (Diluted) 1.92 2.26 2.66 2.81 3.15
Diluted Shares Outstanding 493.86M 455.37M 418.05M 390.13M 373.71M
EBITDA 2.8B 3.09B 3.38B 3.46B 3.35B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 0

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 3

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 2

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 5

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 1

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 5

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Maurices Strengthens Position with Key Refinancing Deal

Updated Category News Views 5

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 1

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading

Top 5 Most Recently Viewed Articles

Memorial Hermann Health System Welcomes New CEO for Children’s Division

Updated Category News Views 263

Memorial Hermann Health System Announces New Leadership Memorial Hermann Health System is excited to share the appointment of Guy B. Giesecke, DHA, as the new Senior Vice President and Chief Executive Officer of Children's Memorial Hermann Hospital. Dr. Giesecke brings a wealth of experience in pediatric healthcare, having dedicated nearly two decades to enhancing...

Continue Reading
PTC Therapeutics Advances with New Drug Application for PKU Drug

Updated Category News Views 288

PTC Therapeutics Moves Forward with PKU Treatment PTC Therapeutics, Inc. (NASDAQ: PTCT) has recently announced an important milestone regarding its New Drug Application (NDA) for sepiapterin, aimed at treating phenylketonuria (PKU), a rare genetic disorder that affects all age groups. The U.S. Food and Drug Administration (FDA) has set a target date for review completion,...

Continue Reading
Wang Lee Group Stock Reaches New Heights with 52-Week Surge

Updated Category News Views 187

Wang Lee Group Achieves Remarkable Stock Performance Wang Lee Group's stock (WLGS) recently celebrated a milestone by reaching a 52-week high of $1.93. This impressive peak indicates robust market confidence and reflects a stunning one-year change of 115.18%. Investors have displayed an increasing interest in WLGS, which has led to this significant rise in stock value...

Continue Reading
ETHSofia Conference Invites Global Blockchain Innovators

Updated Category News Views 203

ETHSofia Conference and Hackathon Showcases Industry Talent SOFIA, Bulgaria - The upcoming ETHSofia Conference and Hackathon stands as a groundbreaking event dedicated to Ethereum and altcoin technology enthusiasts. This first-of-its-kind event in Bulgaria emphasizes a blend of innovation, networking, and learning from industry pioneers. Building the Bridge to Blockchain...

Continue Reading
Fabrinet Highlights Achievements in Corporate Responsibility for 2024

Updated Category News Views 139

Fabrinet's Commitment to Corporate Responsibility Fabrinet, a prominent player in the optical packaging and precision manufacturing industry, recently unveiled its Corporate Responsibility Report for the year ending June 28, 2024. This report reflects the company's unwavering commitment to essential issues such as employee development, community involvement, supply chain...

Continue Reading